Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
    • Our Story
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

G2B joined the Grit International Female Accelerator

News
Grit International Female Accelerator!Grit International Female Accelerator

Gate2Brain has been selected to be part of the 2022 cohort of the Grit International Female Accelerator. This accelerator supports female founders working in digital health and life sciences in over 5 EU countries and the UK.

Gate2Brain attended Barbara Skerritt’s first session  with a #iamremarkable workshop.

 

October 25, 2022/by noticias
Tags: Biotech, entrepreneurship, lifescience, Startup, womanentrepreneur
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/10/grit-cohort-G2B.jpeg 486 800 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-10-25 07:37:262022-10-25 07:38:53G2B joined the Grit International Female Accelerator
You might also like
ACCIOGate2Brain considered one of the most relevants startups in Catalonia Startup Hub
📢 On December 13h, Gate2Brain will be participating together with Maribel Berges (AFFIRMA BIOTECH SL), Sven Dr. Mulfinger (Dana_positive maternal health), and Diana Ballart (The Smart Lollipop) in the i4kids Closing Event 2022, sharing achievements and failures of entrepreneurs in #pediatric and maternal #healthcare.i4kidsi4kids Closing Event 2022
PaidhosGate2Brain wants to deliver drugs to the brain to combat intact barrier brain tumors, such as DIPG
CaixaImpulsGate2Brain as alumni at Caixa Impulse Validate
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.TransfiereGate2Brain in Transfiere – European Forum for Science, Technology & Innovation
G2B receives funding to accelerate its transfer to the market and society
Gate2Brain attends the 1st edition of the, Fundació Bosch i Gimpera, University of Barcelona spin-offs gathering “Cockroaches vs Unicorns”universitat de barcelonaGate2Brain attends the 1st edition of the University of Barcelona spin-offs “Cockroaches vs Unicorns”
THIS IS HOW A DRUG IS TOWED TO THE BRAINExpansiónTHIS IS HOW A DRUG IS TOWED TO THE BRAIN

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025November 3, 2025 - 10:23
  • Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery SolutionsOctober 15, 2025 - 12:56
  • Gate2Brain turns 5!July 9, 2025 - 18:07
  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Gate2Brain’s retreat 2022Gate2Brain's retreat 2022Gate2BrainGORDON CONFERENCESgate2brainGordon Research Conferences
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}